Zidovudine triphosphate mimics

Drug Profile

Zidovudine triphosphate mimics

Alternative Names: Azidothymidine mimics; Azidothymidine triphosphate mimics; AZT-mimics; B-108; B-200; B-446; Zidovudine mimics

Latest Information Update: 26 Mar 2007

Price : $50

At a glance

  • Originator Biota Inc
  • Class
  • Mechanism of Action DNA-directed DNA polymerase inhibitors; Nucleotide reverse transcriptase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Bacterial infections; HIV infections

Most Recent Events

  • 26 Mar 2007 Discontinued - Preclinical for HIV infections treatment in USA (unspecified route)
  • 26 Mar 2007 Discontinued - Preclinical for Bacterial infections in USA (unspecified route)
  • 31 May 2004 Data presented at the 17th International Conference on Antiviral Research (ICAR-2004) have been added to the Viral Infections antimicrobial activity section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top